✦ LIBER ✦

Once-daily initiation with biphasic insulin aspart 30 versus insulin glargine in patients with type 2 diabetes inadequately controlled with oral drugs: an open-label, multinational RCT

✍ Scribed by Strojek, Krzysztof; Bebakar, Wan M.W.; Khutsoane, Duma T.; Pesic, Milica; Šmahelová, Alena; Thomsen, Henrik F.; Kalra, Sanjay

Book ID: 126848612
Publisher: Informa plc
Year: 2009
Tongue: English
Weight: 212 KB
Volume: 25
Category: Article
ISSN: 0300-7995
DOI: 10.1185/03007990903354674

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Comparison of Twice-Daily Biphasic Ins

A Comparison of Twice-Daily Biphasic Insulin Aspart 70/30 and Once-Daily Insulin Glargine in Persons with Type 2 Diabetes Mellitus Inadequately Controlled on Basal Insulin and Oral Therapy: A Randomized, Open-Label Study

✍ Ligthelm, Robert; Gylvin, Titus; DeLuzio, Tony; Raskin, Philip 📂 Article 📅 2011 🏛 American Association of Clinical Endocrinologists 🌐 English ⚖ 781 KB

Superior glycaemic control with once-dai

Superior glycaemic control with once-daily insulin degludec/insulin aspart versus insulin glargine in Japanese adults with type 2 diabetes inadequately controlled with oral drugs: a randomized, controlled phase 3 trial

✍ Onishi, Y.; Ono, Y.; Rabøl, R.; Endahl, L.; Nakamura, S. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 640 KB

Initiation with once-daily BIAsp 30 resu

Initiation with once-daily BIAsp 30 results in superior outcome compared to insulin glargine in Asians with type 2 diabetes inadequately controlled by oral anti-diabetic drugs

✍ Sanjay Kalra; Teresa Plata-Que; Dileep Kumar; Malik Mumtaz; Flemming Søndergaard 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 275 KB

Once-daily basal insulin glargine versus

Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial

✍ Reinhard G Bretzel; Ulrike Nuber; Wolfgang Landgraf; David R Owens; Clare Bradle 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 172 KB

Improved glycaemic control of thrice-dai

Improved glycaemic control of thrice-daily biphasic insulin aspart compared with twice-daily biphasic human insulin; a randomized, open-label trial in patients with type 1 or type 2 diabetes

✍ M. R. Clements; J. Tits; B. T. Kinsley; J. Råstam; H. H. Friberg; R. J. Ligthelm 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 241 KB

Randomized, multinational, open-label, 2

Randomized, multinational, open-label, 2-period, crossover comparison of biphasic insulin aspart 30 and biphasic insulin lispro 25 and pen devices in adult patients with type 2 diabetes mellitus

✍ Leo Niskanen; Linda Elise Jensen; Jacob Råstam; Lars Nygaard-Pedersen; Knut Eric 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 111 KB